Aligos Therapeutics (ALGS) Return on Capital Employed Growth (1y) (2021 - 2026)
Aligos Therapeutics (ALGS) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
31,429.00 |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
16,829.00 |
| 10 |
Aligos Therapeutics |
51.70 Mn |
-28.13 Mn |
- |
7,056.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
7,056.00 |
| Dec 31, 2025 |
14,855.00 |
| Sep 30, 2025 |
3,527.00 |
| Jun 30, 2025 |
3,455.00 |
| Mar 31, 2025 |
-2,304.00 |
| Dec 31, 2024 |
-6,201.00 |
| Sep 30, 2024 |
-644.00 |
| Jun 30, 2024 |
-100.00 |
| Mar 31, 2024 |
959.00 |
| Dec 31, 2023 |
-1,316.00 |
| Sep 30, 2023 |
-3,631.00 |
| Jun 30, 2023 |
-2,065.00 |
| Mar 31, 2023 |
-599.00 |
| Dec 31, 2022 |
-1,879.00 |
| Sep 30, 2022 |
-1,755.00 |
| Jun 30, 2022 |
-1,843.00 |
| Mar 31, 2022 |
-2,831.00 |
| Dec 31, 2021 |
487.00 |
